Company Filing History:
1 out of 9 
1 out of 265 Years Active: 2012
Title: The Innovative Contributions of Adrian Robins
Introduction
Adrian Robins is a notable inventor based in Nottingham, GB. He has made significant contributions to the field of biotechnology, particularly in the development of polypeptides that can enhance immune responses against diseases.
Latest Patents
Robins holds a patent for "Polypeptides capable of binding to CD64 comprising one or more heterologous T cell epitopes and their uses." This invention relates to a polypeptide that includes a portion of human Fc that binds to CD64 and a second portion with heterologous T cell epitopes. The polypeptide can be utilized to stimulate a cytotoxic T cell response, which is crucial for targeting pathogens and tumor cells in patients requiring such treatment. He has 1 patent to his name.
Career Highlights
Throughout his career, Adrian Robins has worked with prominent organizations such as Scancell Limited and Cancer Research Technology Limited. His work has focused on advancing therapeutic strategies that leverage the immune system to combat various diseases.
Collaborations
Robins has collaborated with esteemed colleagues, including Linda Gillian Durrant and Tina Parsons, contributing to the advancement of innovative solutions in the field of immunotherapy.
Conclusion
Adrian Robins exemplifies the spirit of innovation in biotechnology through his patent and collaborative efforts. His work continues to pave the way for new therapeutic approaches in medicine.